Cited by

• Effectiveness, utilisation and cost associated with implantable loop recorders versus external monitors after ischaemic or cryptogenic stroke.

  Dhruva SS, Murillo J, Ameli O, Chaisson CE, Redberg RF, Cohen K. Dhruva SS, et al. Open Heart. 2024 May 8;11(1):e002714. doi: 10.1136/openhrt-2024-002714. Open Heart. 2024. PMID: 38719499 Free PMC article.
• ESC working group on e-cardiology position paper: use of commercially available wearable technology for heart rate and activity tracking in primary and secondary cardiovascular prevention-in collaboration with the European Heart Rhythm Association, European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professionals, Patient Forum, and the Digital Health Committee.

  Jensen MT, Treskes RW, Caiani EG, Casado-Arroyo R, Cowie MR, Dilaveris P, Duncker D, Di Rienzo M, Frederix I, De Groot N, Kolh PH, Kemps H, Mamas M, McGreavy P, Neubeck L, Parati G, Platonov PG, Schmidt-Trucksäss A, Schuuring MJ, Simova I, Svennberg E, Verstrael A, Lumens J. Jensen MT, et al. Eur Heart J Digit Health. 2021 Feb 8;2(1):49-59. doi: 10.1093/ehjdh/ztab011. eCollection 2021 Mar. Eur Heart J Digit Health. 2021. PMID: 36711174 Free PMC article.
• Efficient on-site confirmatory testing for atrial fibrillation with derived 12-lead ECG in a wireless body area network.

  Koya AM, Deepthi PP. Koya AM, et al. J Ambient Intell Humaniz Comput. 2023;14(6):6797-6815. doi: 10.1007/s12652-021-03543-9. Epub 2021 Nov 26. J Ambient Intell Humaniz Comput. 2023. PMID: 34849174 Free PMC article.
• Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation.

  Khurshid S, Mars N, Haggerty CM, Huang Q, Weng LC, Hartzel DN; Regeneron Genetics Center; Lunetta KL, Ashburner JM, Anderson CD, Benjamin EJ, Salomaa V, Ellinor PT, Fornwalt BK, Ripatti S, Trinquart L, Lubitz SA. Khurshid S, et al. Circ Genom Precis Med. 2021 Oct;14(5):e003355. doi: 10.1161/CIRCGEN.121.003355. Epub 2021 Aug 31. Circ Genom Precis Med. 2021. PMID: 34463125 Free PMC article. Clinical Trial.
• Ethical Challenges With Smartwatch-Based Screening for Atrial Fibrillation: Putting Users at Risk for Marketing Purposes?

  Predel C, Steger F. Predel C, et al. Front Cardiovasc Med. 2021 Jan 15;7:615927. doi: 10.3389/fcvm.2020.615927. eCollection 2020. Front Cardiovasc Med. 2021. PMID: 33521064 Free PMC article.